Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Feb;28(2):55-62.
doi: 10.1111/ajad.12862. Epub 2019 Jan 31.

Review article: Effective management of opioid withdrawal symptoms: A gateway to opioid dependence treatment

Thomas R Kosten  1 , Louis E Baxter  2   3   4   5
Affiliations
Review

Review article: Effective management of opioid withdrawal symptoms: A gateway to opioid dependence treatment

Thomas R Kosten et al. Am J Addict. 2019 Feb.

Abstract

Background and objectives: The opioid crisis has taken an immense toll in the United States. On average, five lives are lost to an opioid overdose every hour of the day; estimated costs associated with opioid misuse exceed $500 billion annually. Illicit opioid discontinuation is the first step in the treatment of opioid use disorder (OUD), and transition to an opioid agonist may initiate treatment. However, discontinuation to abstinence from either OUD directly or following agonist treatment results in severely distressing opioid withdrawal symptoms (OWS).

Methods: This review evaluated studies on the etiology, burden, and management of OWS.

Results: Noradrenergic hyperactivity generates many OWS. These OWS can cause patients to relapse during early opioid discontinuation. While agonist therapies are generally first-line for moderate or severe OUD and reduce OWS, prescribing restrictions can limit their availability.

Discussion and conclusions: Non-opioid medications to treat OWS provides a gateway into long-term treatment with naltrexone or psychosocial therapies. For opioid dependent patients without OUD, non-opioid treatments like α-2 adrenergic agonists can facilitate opioid tapering.

Scientific significance: For the millions who are physically dependent on opioids, new treatments for OWS can enhance recovery from OUD and prevent relapse. (© 2019 The Authors. The American Journal on Addictions Published by Wiley Periodicals, Inc.;XX:1-8).

PubMed Disclaimer

References

    1. Booth M. Opium: A History. New York, NY: St Martin's Press; 1996.
    1. Pappas S. Opioid crisis has frightening parallels to drug epidemic of late 1800's. Live Science website. https://www.livescience.com/60559-opioid-crisis-echoes-epidemic-of-1800s... Published September 29, 2017. Accessed March 6, 2018.
    1. Ahrnsbrak R, Bose J, Hedden SL, et al. Key Substance Use and Mental Health Indicators in the United States: Results from the 2016 National Survey on Drug Use and Health (HHS Publication No. SMA 17‐5044, NSDUH Series H‐52). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; September 2017. https://www.samhsa.gov/data/sites/default/files/NSDUH-FFR1-2016/NSDUH-FF... Accessed March 6, 2018.
    1. Drug overdose death data. Centers for Disease Control and Prevention website. https://www.cdc.gov/drugoverdose/data/statedeaths.html Updated December 19, 2017. Accessed March 6 2018.
    1. Kochanek KD, Murphy SL, Xu J, et al. Mortality in the United States, 2016. Hyattsville, MD: National Center for Health Statistics; December 2017. https://www.cdc.gov/nchs/data/databriefs/db293.pdf Accessed March 8, 2018.

Publication types

MeSH terms

Substances